| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia
|
Medeiros, Bruno C.
|
|
2018
|
18 |
5 |
p. 346-352.e5
|
artikel
|
| 2 |
Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma
|
Gandhi, Ujjawal H.
|
|
2018
|
18 |
5 |
p. 335-345
|
artikel
|
| 3 |
Editorial Board
|
|
|
2018
|
18 |
5 |
p. A5-A6
|
artikel
|
| 4 |
Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease
|
Collinge, Elodie
|
|
2018
|
18 |
5 |
p. e211-e218
|
artikel
|
| 5 |
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment
|
Okada, Masaya
|
|
2018
|
18 |
5 |
p. 353-360.e1
|
artikel
|
| 6 |
L-carnitine and Vitamin B Complex for the Treatment of Pegasparaginase-induced Hyperbilirubinemia
|
Rausch, Caitlin R.
|
|
2018
|
18 |
5 |
p. e191-e195
|
artikel
|
| 7 |
Leukocytoclastic Vasculitis and Desensitization to High-dose Methotrexate in Primary Central Nervous System Lymphoma
|
Hanna, Colette
|
|
2018
|
18 |
5 |
p. e197-e200
|
artikel
|
| 8 |
Multiple Myeloma: Clinical Updates From the American Society of Hematology Annual Meeting, 2017
|
Terpos, Evangelos
|
|
2018
|
18 |
5 |
p. 321-334
|
artikel
|
| 9 |
Prognostic Effect of CD20 Expression in Adult B-cell Acute Lymphoblastic Leukemia
|
Esteban, Reibán-Espinoza
|
|
2018
|
18 |
5 |
p. 361-367
|
artikel
|
| 10 |
“Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions”—Treatment of ALL
|
Chiaretti, Sabina
|
|
2018
|
18 |
5 |
p. 301-310
|
artikel
|
| 11 |
Table of Contents
|
|
|
2018
|
18 |
5 |
p. A7, A12-A13
|
artikel
|
| 12 |
Thiotepa 10 mg/kg Treatment Regimen Is Superior to Thiotepa 5 mg/kg in TBF Conditioning in Patients Undergoing Allogeneic Stem-Cell Transplantation
|
El-Cheikh, Jean
|
|
2018
|
18 |
5 |
p. 368-374
|
artikel
|
| 13 |
Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics
|
Ma, Vincent T.
|
|
2018
|
18 |
5 |
p. e201-e210
|
artikel
|
| 14 |
Various Signaling Pathways in Multiple Myeloma Cells and Effects of Treatment on These Pathways
|
Dehghanifard, Ali
|
|
2018
|
18 |
5 |
p. 311-320
|
artikel
|
Tijdschrift beschrijving